- Home
- Immunology
- Contents
Medical Article
Welcome to MedX – Your Source for the Latest Medical Breakthroughs! FDA Approves First Treatment for IgG4-Related Disease – Inebilizumab becomes the first and only FDA-approved therapy for this rare, multi-organ immune condition, cutting flares by 87% in Phase 3 trials. Atrasentan Offers New Hope for IgA Nephropathy – The FDA grants accelerated app

3349 Reached1 Comments1 Likes
Medical Article
Hello and a Warm Welcome to MedX, Today's Updates Include: Phase 4 Study Found Lower-Dose Yellow Fever Vaccine Effective ACC/AHA Updates Acute Coronary Syndrome Guidelines for 2025 HPV Vaccine Linked to 80% Drop in Cervical Precancers, CDC Reports Qatar Announces Healthcare Sector Working Hours for Ramadan Tezepelumab: Breakthrough for Nasal Polyps

4471 Reached3 Comments1 Likes